Accelerating DRUG DISCOVERY for Frontotemporal Degeneration

ALZHEIMER’S DRUG DISCOVERY FOUNDATION (ADDF)

Object

Topic: Alzheimer.

Destination: The Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) seek to accelerate this progress by supporting innovative small molecule and biologic (antibodies, oligonucleotides, peptides, gene therapy etc.) drug development programs for FTD through this request for proposals (RFP).

Budget: $150,000-$200,000.

Duration: 1 year

 

Are you interested in this call?

Are you interested?

Fill out the form below to receive more information: